OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Optimizing these processes involves modifying various variables, including cell line engineering, media composition, and bioreactor settings. A key goal is to amplify antibody yield while minimizing production expense